Who owns Monopar Therapeutics Inc.?
Institutional ownership of MNPR from SEC Form 13F filings across 68 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
68
13F holders
$342.2M
value, 2026 filers
55.2%
of shares outstanding (3.7M sh)
20
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of MNPR's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Jupiter Topco LLCNEW | 1.3M | $121.7M | 0.0% | 19.6% | new |
| 2 | BlackRock, Inc. | 348,819 | $32.3M | 0.0% | 5.2% | +10.2% |
| 3 | Polar Capital Holdings Plc | 214,469 | $19.9M | 0.0% | 3.2% | -5.3% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 209,711 | $19.4M | 0.0% | 3.1% | -52.0% |
| 5 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 209,195 | $19.4M | 0.0% | 3.1% | -32.3% |
| 6 | TCG Crossover Management, LLC | 203,327 | $18.8M | 0.5% | 3% | +53.9% |
| 7 | WELLINGTON MANAGEMENT GROUP LLP | 158,437 | $14.7M | 0.0% | 2.4% | -9.1% |
| 8 | Candriam S.C.A.NEW | 143,339 | $13.3M | 0.1% | 2.1% | new |
| 9 | Balyasny Asset Management L.P. | 134,543 | $12.5M | 0.0% | 2% | -1.4% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 112,578 | $10.4M | 0.0% | 1.7% | +12.7% |
| 11 | Bank of New York Mellon Corp | 76,942 | $7.1M | 0.0% | 1.1% | -2.1% |
| 12 | Longaeva Partners L.P.NEW | 55,834 | $5.2M | 0.1% | 0.8% | new |
| 13 | NEUBERGER BERMAN GROUP LLC | 55,194 | $5.1M | 0.0% | 0.8% | +30.1% |
| 14 | MILLENNIUM MANAGEMENT LLC | 50,311 | $4.7M | 0.0% | 0.8% | -5.0% |
| 15 | VANGUARD PORTFOLIO MANAGEMENT LLC | 48,816 | $4.5M | 0.0% | 0.7% | +6.2% |
| 16 | CITADEL ADVISORS LLC | 37,004 | $3.4M | 0.0% | 0.6% | -36.7% |
| 17 | NORTHERN TRUST CORP | 34,641 | $3.2M | 0.0% | 0.5% | +8.7% |
| 18 | DEUTSCHE BANK AG\ | 31,008 | $2.9M | 0.0% | 0.5% | +7.6% |
| 19 | VANGUARD FIDUCIARY TRUST CO | 28,280 | $2.6M | 0.0% | 0.4% | -0.6% |
| 20 | UBS Group AG | 27,259 | $2.5M | 0.0% | 0.4% | -30.9% |
| 21 | MORGAN STANLEY | 17,919 | $1.7M | 0.0% | 0.3% | -19.7% |
| 22 | AMERIPRISE FINANCIAL INC | 17,800 | $1.6M | 0.0% | 0.3% | +161.0% |
| 23 | GOLDMAN SACHS GROUP INC | 16,161 | $1.5M | 0.0% | 0.2% | -53.4% |
| 24 | Russell Investments Group, Ltd. | 14,850 | $1.4M | 0.0% | 0.2% | +4.2% |
| 25 | BOOTHBAY FUND MANAGEMENT, LLCNEW | 14,689 | $1.4M | 0.0% | 0.2% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.